These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10401453)

  • 21. Clinical characteristics of hospitalized psychotic patients who refuse antipsychotic drug therapy.
    Zito JM; Routt WW; Mitchell JE; Roerig JL
    Am J Psychiatry; 1985 Jul; 142(7):822-6. PubMed ID: 2861754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C; Schulz E; Remschmidt H
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project.
    Bola JR; Mosher LR
    J Nerv Ment Dis; 2003 Apr; 191(4):219-29. PubMed ID: 12695732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic reassessment and treatment response in schizophrenia.
    Honer WG; Smith GN; MacEwan GW; Kopala L; Altman S; Yorkston N; Ehmann TS; Smith A; Lang M
    J Clin Psychiatry; 1994 Dec; 55(12):528-32. PubMed ID: 7814346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent and predictive validity of the personality disorder diagnosis in adolescent inpatients.
    Levy KN; Becker DF; Grilo CM; Mattanah JJ; Garnet KE; Quinlan DM; Edell WS; McGlashan TH
    Am J Psychiatry; 1999 Oct; 156(10):1522-8. PubMed ID: 10518161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of medication-free research.
    Carpenter WT
    Schizophr Bull; 1997; 23(1):11-8. PubMed ID: 9050109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotic patients' understanding of informed consent.
    Irwin M; Lovitz A; Marder SR; Mintz J; Winslade WJ; Van Putten T; Mills MJ
    Am J Psychiatry; 1985 Nov; 142(11):1351-4. PubMed ID: 2865904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia.
    Frazier JA; Gordon CT; McKenna K; Lenane MC; Jih D; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):658-63. PubMed ID: 8056728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood-onset schizophrenia: the challenge of diagnosis.
    Gochman P; Miller R; Rapoport JL
    Curr Psychiatry Rep; 2011 Oct; 13(5):321-2. PubMed ID: 21713647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complete neuroleptic withdrawal in patients with schizophrenia with intense symptoms and resistant to treatment].
    Wolf MA; Bailly L; Diener JM; Martinet JP; Peretti S; Garneau Y
    Encephale; 1991; 17(4):255-61. PubMed ID: 1683626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic and follow-up typological characteristics of early schizophrenia].
    Eggers C; Klapal M
    Fortschr Neurol Psychiatr; 1997 Apr; 65(4):154-70. PubMed ID: 9235308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smooth pursuit eye-tracking impairment in childhood-onset psychotic disorders.
    Kumra S; Sporn A; Hommer DW; Nicolson R; Thaker G; Israel E; Lenane M; Bedwell J; Jacobsen LK; Gochman P; Rapoport JL
    Am J Psychiatry; 2001 Aug; 158(8):1291-8. PubMed ID: 11481165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study.
    Werry JS; McClellan JM; Chard L
    J Am Acad Child Adolesc Psychiatry; 1991 May; 30(3):457-65. PubMed ID: 2055884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.